IGC Receives New Patent from U.S. Patent Office to Treat Cachexia and Eating Disorders in Humans and Veterinary Animals March 26, 2020March 27, 2020 by charlie
IGC Reports Financial Results for the Quarter Ended December 31st, 2019 February 11, 2020February 11, 2020 by charlie
IGC Announces IRB Approval of its IGC-AD1 for a Phase-2 Study September 19, 2019November 6, 2019 by Rachel
